Investing in Halozyme Therapeutics is a compelling way to gain exposure to the broader healthcare and biotechnology ...
If you are looking for yield as 2025 draws to a close, this pair of dividend stocks looks set to reward you for decades to ...
The S&P 500 has risen about 16% this year and is hovering near its all-time high. It looks historically expensive at 31 times ...
Social Security rules can be confusing for seniors, but it's important to know the basics to make informed choices.
The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. This drugmaker has a strong ...
Domino's has 21,700 stores in 90 global markets, making it the leader in pizza stores. Pizza is a resilient category, since ...
The asset-lite business model allows Booking Holdings to generate lucrative profits. The travel company is benefiting as ...
The Amex Platinum looks expensive at first, but its credits, perks, and travel benefits can easily outweigh the annual fee.
Fiscal 2025 marked a clear turn in Apple's fundamentals.
Tilray just implemented a reverse stock split to avoid being delisted from stock exchanges. The company's performance in ...
Ferrari's sell-off after its October investor event has created a rare opportunity to buy the shares of the iconic brand at a ...
That's when accounting for the stock's total return, which includes both capital gains and the company's regular quarterly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results